Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Capital Leases (2023 - 2025)

Camp4 Therapeutics' Capital Leases history spans 3 years, with the latest figure at $47000.0 for Q3 2025.

  • On a quarterly basis, Capital Leases fell 45.98% to $47000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $47000.0, a 45.98% decrease, with the full-year FY2024 number at $70000.0, down 52.7% from a year prior.
  • Capital Leases hit $47000.0 in Q3 2025 for Camp4 Therapeutics, down from $59000.0 in the prior quarter.
  • Over the last five years, Capital Leases for CAMP hit a ceiling of $148000.0 in Q4 2023 and a floor of $47000.0 in Q3 2025.
  • Historically, Capital Leases has averaged $78166.7 across 3 years, with a median of $64500.0 in 2024.
  • Biggest five-year swings in Capital Leases: tumbled 52.7% in 2024 and later plummeted 45.98% in 2025.
  • Tracing CAMP's Capital Leases over 3 years: stood at $148000.0 in 2023, then tumbled by 52.7% to $70000.0 in 2024, then crashed by 32.86% to $47000.0 in 2025.
  • Business Quant data shows Capital Leases for CAMP at $47000.0 in Q3 2025, $59000.0 in Q2 2025, and $58000.0 in Q1 2025.